Deal Type

Omron Healthcare, a medical equipment company for home health monitoring and treatment based in Japan, has acquired Luscii Healthtech, a Netherlands-based scale-up in the...

Nasdaq-listed, Copenhagen-headquartered Genmab, an international biotechnology company, is to acquire US-based ProfoundBio, a privately-owned clinical-stage biotechnology company developing next-generation ADCs and ADC technologies for...

Blue Wolf Capital Partners, a middle market private equity firm specializing in the healthcare and industrial sectors, is to form a new CDMO platform...

Ampersand Capital Partners portfolio company, Specac, a manufacturer of spectroscopy accessories and sample prep solutions, has acquired US-based Harrick Scientific, a manufacturer of high-quality...

Abu Dhabi-based investment and holding company, ADQ, has consolidated its existing assets in the life sciences sector to form a global holding company, Arcera. ADQ’s...

Funds managed by Munich-based Castik Capital, a European private equity investor, has entered into an agreement to acquire Mentha’s majority stake in paraDIGMA groep,...

Galderma, the pure-play dermatology business that recently listed on the SIX Swiss exchange, has taken total size of the transaction to around CHF2.3bn (US$2.54bn)...

India-based Veeda Clinical Research, a full-service CRO, has acquired Heads, a privately held, Ireland-based CRO that specializes in conducting clinical trials in oncology. The...

Kelix bio, an emerging markets biopharmaceuticals platform, including its four subsidiaries, is to be acquired by Mubadala Investment Company, the Abu Dhabi investor with...

Novo Nordisk is to acquire Cardior Pharmaceuticals for up to €1.025bn (US$1.11bn), including an upfront payment and additional payments subject to certain development and...